Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (231-240 of 436) with videos related to

Pageof 44
Sort By:
Thrombosis and Haemostasis|December 30, 2004
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonistRichard C Becker, John Alexander, You Fu Li, et al.
Thrombosis and Haemostasis|October 12, 2012
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitorMark Y Chan, Min Lin, Joseph Lucas, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2017
Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromesDawid L Staudacher, Vera Putz, Lukas Heger, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|February 16, 2013
Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart diseaseWei Jiang, Zainab Samad, Stephen Boyle, et al.
Journal of the American College of Cardiology|September 14, 2010
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyRobert F Storey, Dominick J Angiolillo, Shankar B Patil, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2016
Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk PatientsDavid A Johnson, David Lieberman, John M Inadomi, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
The American Journal of Gastroenterology|November 26, 2009
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal proceduresRichard C Becker, James Scheiman, Harold L Dauerman, et al.
Pageof 44

Showing results (231-240 of 436) with videos related to

Sort By:
Pageof 44
Thrombosis and Haemostasis|December 30, 2004
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonistRichard C Becker, John Alexander, You Fu Li, et al.
Thrombosis and Haemostasis|October 12, 2012
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitorMark Y Chan, Min Lin, Joseph Lucas, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2017
Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromesDawid L Staudacher, Vera Putz, Lukas Heger, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|February 16, 2013
Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart diseaseWei Jiang, Zainab Samad, Stephen Boyle, et al.
Journal of the American College of Cardiology|September 14, 2010
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyRobert F Storey, Dominick J Angiolillo, Shankar B Patil, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2016
Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk PatientsDavid A Johnson, David Lieberman, John M Inadomi, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
The American Journal of Gastroenterology|November 26, 2009
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal proceduresRichard C Becker, James Scheiman, Harold L Dauerman, et al.
Pageof 44